Bengaluru/Frankfurt — GlaxoSmithKline (GSK), the world’s largest vaccine maker, laid out plans on Thursday to produce 1-billion doses of vaccine efficacy boosters for Covid-19 shots next year, as the race to develop a successful solution to the coronavirus crisis heats up.

The British drugmaker said it is in talks with governments to back the manufacturing expansion of the boosters, or adjuvants, that will help scale up production of future vaccines for Covid-19, the disease caused by the novel coronavirus...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now